Evidence map›Paper›PMID 41549825›Full record

ArticleThe veterinary quarterly2026

Antiviral effect of poly(styrene 4-sulfonate) (PSSNa) on feline calicivirus oral infections in cats-field study.

Aleksandra Synowiec, Magdalena Pachota, Martyna Krejmer-Rabalska, Daria Ziemann, Krzysztof Szczubiałka, Michal Jank, Lukasz Rabalski, Maria Nowakowska, Jerzy P Gawor, Krzysztof Pyrć

Abstract readRandomized Controlled Trial, Veterinary
PubMed Full text at PMC Publisher
In one paragraph

Article in The veterinary quarterly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aleksandra SynowiecMalopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.ORCID 0000-0001-9846-6922
Magdalena PachotaMalopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.ORCID 0000-0001-5520-6979
Martyna Krejmer-RabalskaLaboratory of Recombinant Vaccines, Intercollegiate Faculty of Biotechnology, University of Gdansk, Medical University of Gdansk, Gdansk, Poland.ORCID 0000-0002-5263-6081
Daria ZiemannVeterinary Clinic Arka, Kraków, Poland.
Krzysztof SzczubiałkaAcatavir Ltd Company, Kraków, Poland.ORCID 0000-0001-6612-1102
Michal JankAcatavir Ltd Company, Kraków, Poland.ORCID 0000-0003-1630-2938
Lukasz RabalskiLaboratory of Recombinant Vaccines, Intercollegiate Faculty of Biotechnology, University of Gdansk, Medical University of Gdansk, Gdansk, Poland.ORCID 0000-0002-5292-9263
Maria NowakowskaAcatavir Ltd Company, Kraków, Poland.ORCID 0000-0001-6456-5463
Jerzy P GaworVeterinary Clinic Arka, Kraków, Poland.ORCID 0000-0001-9096-5671
Krzysztof PyrćMalopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.ORCID 0000-0002-3867-7688

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Feline calicivirus (FCV) infection causes nasal discharge, oral mucosa inflammation, ulcerations, gingivitis, and conjunctivitis, often progressing to chronic gingivostomatitis, severe pneumonia, and fatal systemic infections. With no antivirals currently available, poly(sodium 4-styrene sulfonate) (PSSNa) was identified in 2019 as a safe inhibitor

Indexed as

Antiviral AgentsCaliciviridae InfectionsCalicivirus, FelineCat DiseasesMouth DiseasesPolystyrenesSulfonic AcidsAnimalsCatsDouble-Blind MethodFemaleMaleAntiviral AgentsPolystyrenespolystyrene sulfonic acidSulfonic AcidsantiviralsFeline calicivirus (FCV)field studiespoly(sodium 4-styrene sulfonate)PSSNa

Identifiers

PMID41549825
PMCPMC12818315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.